retatrutide ישראל Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Crime gangs in UK making

"The challenge for a lot of our independents will be what they can actually accept," Elliott said

Ive had a few patients with bulimia, and its not certain whether it would be safe or not to put them on it, Jay said

The vast majority of coverage of the drugs is provided by government health plans, largely state Medicaid plans, according to Leverage

Long-Term Health Considerations For some individuals, especially those with obesity-related health conditions (like type 2 diabetes, high blood pressure, or cardiovascular issues), staying on GLP-1 medications for the long term might be necessary to manage overall health, not just weight loss

Heres a breakdown of what to expect: Average Monthly Costs: Some of these medications are typically $800 $1,500 without insurance